Sheldon L. Koenig is CEO & President at Esperion Therapeutics, Inc. (ESPR). They have made 15 open-market trades across 1 company since 2022, most recently 2026-06-17.
CIK 0001766524
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $75K since 2022, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ESPR | 2,119,111 | $6.8M |
| PTLA | 488 | $9K |
| Total | $6.8M |
Shares reported on the most recent Form 4, priced at the 2026-06-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ESPR | SELL | 2026-06-17 | 2026-06-18 | $3.16 | $169K | +0.2% | N/A | N/A |
| ESPR | SELL | 2026-03-17 | 2026-03-18 | $2.72 | $139K | +5.2% | -18.6% | +26.2% |
| ESPR | SELL | 2025-12-17 | 2025-12-18 | $3.67 | $354K | -2.1% | -23.5% | -33.7% |
| ESPR | SELL | 2025-09-17 | 2025-09-18 | $2.79 | $159K | -6.4% | -0.4% | +29.0% |
| ESPR | SELL | 2025-06-17 | 2025-06-18 | $1.11 | $34K | -9.1% | +6.4% | +151.8% |
| ESPR | SELL | 2025-03-18 | 2025-03-19 | $1.50 | $20K | -11.1% | -47.4% | -32.7% |
| ESPR | SELL | 2024-12-17 | 2024-12-18 | $2.47 | $31K | +0.5% | +0.9% | -27.9% |
| ESPR | SELL | 2024-09-17 | 2024-09-18 | $1.80 | $26K | -6.8% | +15.3% | +39.0% |
| ESPR | BUY | 2023-05-09 | 2023-05-10 | $1.26 | $25K | +12.2% | -12.2% | +9.5% |
| ESPR | SELL | 2023-03-17 | 2023-03-20 | $1.78 | $12K | +8.4% | -14.9% | -0.6% |
| ESPR | SELL | 2023-03-07 | 2023-03-08 | $5.06 | $28K | -69.3% | -72.7% | -72.7% |
| ESPR | SELL | 2022-09-19 | 2022-09-20 | $6.94 | $24K | -7.1% | +13.9% | -18.2% |
| ESPR | BUY | 2022-08-05 | 2022-08-08 | $5.80 | $50K | +10.2% | +19.9% | +28.4% |
| ESPR | SELL | 2022-06-17 | 2022-06-21 | $4.99 | $23K | +14.0% | +14.0% | +31.6% |
| ESPR | SELL | 2022-03-17 | 2022-03-18 | $4.58 | $3K | -2.0% | +0.8% | -1.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.